
1 / 3Growth Factor & Tissue Signaling Research · Oral Research Compounds
$168.00$67.20Save 60%
Quantity
$168.00$67.20
SLU-PP-332 is a synthetic small-molecule pan-agonist of the estrogen-related receptors ERRα, ERRβ and ERRγ, a family of orphan nuclear receptors first characterized in academic pharmacology programs. Although it is catalogued alongside research peptides, it is an orally formulated small molecule that appears in published work on ERR-mediated transcription, mitochondrial biogenesis pathways and oxidative metabolism gene programs in cell and animal models.
Real Peptides supplies SLU-PP-332 as capsules in a 100 count bottle, finished in the United States. Every batch is assayed by an independent laboratory, and the certificate of analysis for the current lot is published in the lab results section so it can be reviewed before purchase. Orders ship from Florida and California within 24 hours. Material is sold for laboratory research use only and is not for human or animal consumption.
SLU-PP-332 Capsules · 250mcg (100 Capsules)
$67.20$168.00
Recommended with this order
Frequently paired with this compound by other researchers.
Lab results · certificate of analysis
Every node is a test the laboratory ran on this batch — read straight off this product's certificate in our COA registry. Tap a node for the standard it had to meet and the result that came back.
Purity
99.684%
Average purity across the conformity vials pulled from this batch, by HPLC. The per-vial figures print further down the certificate.
hover to hold · tap a node for the standard and the result
For Research Use Only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Not for food, drug, or cosmetic use.
99% Pure | 100 Capsules | Finished in the USA
SLU-PP-332 is a small-molecule pan-agonist of the estrogen-related receptors (ERRα, ERRβ, ERRγ), a family of orphan nuclear receptors. It appears in published research examining ERR-mediated transcription, mitochondrial biogenesis pathways, and oxidative metabolism gene programs in model systems.
For Research Use Only. Not for human or veterinary use.

SLU-PP-332 is a small-molecule agonist of the estrogen-related receptor family — ERRα, ERRβ, and ERRγ. It was developed at Saint Louis University, from which it takes its name.
ERRs are orphan nuclear receptors: they have no identified endogenous ligand, which historically made them difficult to study pharmacologically. Synthetic agonists such as SLU-PP-332 are therefore valuable research tools. Published work examines ERR-mediated transcription, mitochondrial biogenesis pathways, and oxidative metabolism gene programs in skeletal muscle cell models.


Growth Factor & Tissue Signaling Research compounds
Research library